Arqule News
10 ASCO '13 Abstracts You Can Read Right Now
May 15Get a head start on searching through ASCO abstracts with these 10 summaries.
Narrower-than-Expected Loss at ArQule - Analyst Blog
Zacks May 9ArQule recently reported a loss of 9 cents per share in the first quarter of 2013, narrower than the Zacks Consensus Estimate of a loss of 11 cents per share.
ArQule Management Discusses Q1 2013 Results - Earnings Call Transcript
Seeking Alpha May 8ArQule Management Discusses Q1 2013 Results - Earnings Call Transcript
Arqule, Inc. (ARQL) Posts Q1 Loss of 9c/Share
Street Insider May 8ArQule Reports First Quarter 2013 Financial Results
Business Wire May 8ArQule, Inc. today announced its financial results for the first quarter of 2013.
ArQule to Report First Quarter 2013 Financial Results on May 8, 2013
Business Wire May 1ArQule, Inc. today announced that it will report its financial results for the first quarter of 2013 on Wednesday, May 8, 2013 at 7:00 a.m. Eastern Time. The Company will hold a conference call at 9:00 a.m.
ArQule, Inc. to Present at Needham 12th Annual Healthcare Conference
Business Wire Apr 23ArQule, Inc. today announced that the Company will present at the Needham 12th Annual Healthcare Conference on Tuesday, April 30, 2013 at 10:40 a.m. The presentation
Data on ArQule's ARQ 092
Apr 10Data on ArQule's ARQ 092 - Analyst Blog
Zacks Apr 10Researchers recently presented data on ArQule's ARQ 092 at the AACR Annual Meeting held in Washington, D.C. which revealed that the candidate inhibits the AKT pathway and proved to be quite safe in an ongoing phase I clinical trial.
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| ARQL | 2.775 | -0.01 | -0.18% | 173.78M |
